Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x100px

Document › Details

Armstrong, Annalee / Bayer, Max / Masson, Gabrielle [Fierce Biotech]. (12/22/23). "News: Fierce Biotech M&A Tracker 2023. BMS, AbbVie Drop Billions for Neuropsychiatry Biotechs".

	Organisation	Bristol Myers Squibb Co. (BMS) (NYSE: BMY)
	Group	Bristol Myers Squibb (BMS) (Group)
	Organisation 2	AbbVie Inc. (NYSE: ABBV)
	Group	AbbVie (Group)
	Product	pharmaceutical
	Product 2	biopharmaceutical

Original document
accessed by [iito] on 2024-01-02

Record changed: 2024-01-31

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for Bristol Myers Squibb (BMS) (Group)

[1] VantAI. (2/13/24). "Press Release: VantAI Enters Collaboration With Bristol Myers Squibb to Accelerate Molecular Glue Drug Discovery Through Artificial Intelligence". New York, NY....
[2] GlycoEra AG. (1/5/24). "Press Release: GlycoEra AG Announces New Investor, Appoints Industry Veteran Greg Fralish as Chief Business Officer". Newton, MA & Wädenswil....
[3] Bristol Myers Squibb Company. (12/26/23). "Press Release: Bristol Myers Squibb Adds Premier Radiopharmaceutical Platform with Acquisition of RayzeBio". Princeton, NJ & San Diego, CA....
[4] Bristol Myers Squibb Company. (12/22/23). "Press Release: Bristol Myers Squibb Strengthens Neuroscience Portfolio with Acquisition of Karuna Therapeutics". Princeton, N.J. & Boston, MA....
[5] RayzeBio, Inc.. (9/19/23). "Press Release: RayzeBio, Inc. Announces Closing of Upsized $358 Million Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares". San Diego, CA....
[6] RayzeBio, Inc.. (9/14/23). "Press Release: RayzeBio, Inc. Announces Pricing of Upsized $311 Million Initial Public Offering". San Diego, CA....
[7] Immatics N.V.. (7/24/23). "Press Release: Immatics Announces $35 Million Equity Investment from Bristol Myers Squibb". Tübingen & Houston, TX....
[8] Evotec SE. (7/11/23). "Press Release: Evotec and Bristol Myers Squibb Enter Licence Agreement within Neuroscience Partnership". Hamburg....
[9] Evotec SE. (5/12/23). "Press Release: Evotec Publishes Annual Report 2022 and Quarterly Statement for Q1 2023". Hamburg....
[10] Tubulis GmbH. (4/20/23). "Press Release: Tubulis Announces Strategic License Agreement with Bristol Myers Squibb to Develop Next Generation ADCs for the Treatment of Cancer Patients". Munich....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]